NKTX

1.1452.23%
SR

Shawn Rose

Chief Medical Officer and Head of Research & Development

Dr. Shawn Rose, M.D. Ph.D. is Chief Development Officer of Immunology at Vividion Therapeutics, Inc. from September 07, 2023. Dr. Rose joined the Vividion Therapeutics, Inc. on September 07, 2023. Dr. Rose is Chief Medical Officer and Head of Research & Development of Nkarta, Inc. from June 23, 2025. Dr. Rose was Senior VP & Head of Clinical Development of Magenta Therapeutics, Inc. from August 15, 2022 until February 2023. Dr. Rose joined the Magenta Therapeutics, Inc. in February 2022. Prior to joining the Company, Dr. Rose served as Vice President, Clinical Development of Annexon Biosciences where he served as the Head of Immunology Development and Clinical Pharmacology and prior to that, Dr. Rose had roles of increasing responsibility in clinical development in immunology and translational medicine at Janssen and Bristol Myers Squibb. Dr. Rose holds an M.D. degree and a Ph.D. degree in Immunology from the University of Miami Miller School of Medicine. Dr. Rose did his postdoctoral training in Medicine and Fellowship in Rheumatology at the Northwestern University Feinberg School of Medicine. He received his undergraduate degree from the University of Miami, with a Bachelor of Science in Psychobiology.

Positions